Table 3 Characteristics and outcomes for studies published during 2018鈥�2022 (N鈥�=鈥�9)
Author (Year)** | Location | Population served | No. participants | Survivals* | Deaths* | Included in meta-analyses | ||
|---|---|---|---|---|---|---|---|---|
Studies reporting individual-level data | ||||||||
Lintzeris (2020) | Australia | 笔奥鲍顿鈥� | 145 | 9 | (100.0%) | 0 | (0.0%) | Yes |
Buresh (2020) | Baltimore | PWUD | 346 | 68 | (95.8%) | 3 | (4.2%) | Yes |
Jones (2022) | New York | PWUD | 321 | 161 | (97.0%) | 5 | (3.0%) | Yes |
Troberg (2022) | Sweden | PWUD | 165鈥� | 123 | (100.0%) | 0 | (0.0%) | Yes |
Janssen (2020) | Michigan | Police | 508 | 174 | (94.6%) | 10 | (5.4%) | Yes |
Williams (2021) | Canada | Community service providers | 狈搁搂 | 1,517 | (98.5%) | 23 | (1.5%) | No |
Yang (2021) | United States | 惭颈虫别诲露 | 3,609 | 335 | (97.4%) | 9 | (2.6%) | No |
Thylstrup (2019) | Denmark | Mixed# | 552 | 23 | (95.8%) | 1 | (4.2%) | No |
Total | 听 | 听 | 5,646 | 2,410 | 听 | 51 | 听 | 听 |
Study reporting community-level data | ||||||||
Naumann (2019) | No. Carolina | 听 | 352 overdose deaths averted/3 years | No | ||||